Compare $ACTU vs $AKTX | Chartloom

Compare

$ACTU vs $AKTX

Actuate Therapeutics Inc · Akari Therapeutics PLC

ACTU

Actuate Therapeutics Inc

AKTX

Akari Therapeutics PLC

Compare $ACTU vs $AKTX

Comparing Actuate Therapeutics Inc and Akari Therapeutics PLC

ACTUActuate Therapeutics Inc

AKTXAkari Therapeutics PLC

ACTUActuate Therapeutics Inc

Market cap

$15M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-89.9%

52W performance

-91.3%

FCF yield

-135.8%

AKTXAkari Therapeutics PLC

Market cap

$17M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-24.4%

52W performance

-78.5%

FCF yield

-63.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ACTU

AKTX

Detailed metrics comparison

ACTU

Actuate Therapeutics Inc

AKTX

Akari Therapeutics PLC

Market Cap

ACTU$15M

AKTX$17M

Enterprise Value

ACTU$11M

AKTX$10M

Price

ACTU$0.61

AKTX$8.77

P/E Ratio

ACTUN/A

AKTXN/A

P/S Ratio

ACTU0.00x

AKTX0.00x

EV/Sales

ACTU0.00x

AKTX0.00x

EV/EBITDA

ACTU0.00x

AKTX0.00x

P/B Ratio

ACTU19.88x

AKTX0.83x

P/FCF Ratio

ACTUN/A

AKTXN/A

EV/FCF

ACTU-0.53x

AKTX-0.94x

PEG Ratio

ACTUN/A

AKTXN/A

Forward P/E (NTM)

ACTUN/A

AKTXN/A

Forward P/S (NTM)

ACTUN/A

AKTXN/A

Revenue (TTM)

ACTU$0

AKTX$0

Revenue Growth (YoY)

ACTUN/A

AKTXN/A

Forward Rev Growth

ACTU50.1%

AKTX137.9%

Gross Margin (TTM)

ACTU0.0%

AKTX0.0%

Operating Margin (TTM)

ACTU0.0%

AKTX0.0%

EBITDA Margin (TTM)

ACTU0.0%

AKTX0.0%

Net Margin (TTM)

ACTU0.0%

AKTX0.0%

FCF Margin (TTM)

ACTUN/A

AKTXN/A

Net Income (TTM)

ACTU$-20M

AKTX$-31M

FCF (TTM)

ACTU$-20M

AKTX$-11M

EPS (TTM)

ACTU-$0.86

AKTX-$0.40

ROE (TTM)

ACTU-34618.0%

AKTX-14745.0%

ROA (TTM)

ACTU-17840.0%

AKTX-7470.0%

ROIC (TTM)

ACTU-32397.0%

AKTX-14027.0%

Cash

ACTU$4M

AKTX$8M

Debt

ACTU$405K

AKTX$693K

Net Cash/Debt

ACTU$4M

AKTX$7M

Current Ratio (TTM)

ACTU1.25x

AKTX0.60x

Quick Ratio (TTM)

ACTU1.16x

AKTX0.56x

Debt/Equity (TTM)

ACTU0.41x

AKTX0.04x

Debt/Assets (TTM)

ACTU0.0%

AKTX0.0%

Interest Coverage (TTM)

ACTUN/A

AKTXN/A

Net Debt/EBITDA (TTM)

ACTU0.00x

AKTX0.00x

Beta

ACTU1.66

AKTX1.48

52W Performance

ACTU-91.3%

AKTX-78.5%

YTD Performance

ACTU-89.9%

AKTX-24.4%

% from 52W High

ACTU-92.8%

AKTX-79.5%

% from 52W Low

ACTU1.0%

AKTX190.4%

Asset Turnover (TTM)

ACTU0.00x

AKTX0.00x

FCF Yield (TTM)

ACTU-135.8%

AKTX-63.0%

Earnings Yield (TTM)

ACTU-140.1%

AKTX-181.3%

Dividend Yield (TTM)

ACTUN/A

AKTXN/A

Rule of 40

ACTU0.0

AKTX0.0

EV/GP/RG

ACTUN/A

AKTXN/A

Ticker research

View ACTU research View AKTX research

Metric	ACTU Actuate Therapeutics Inc	AKTX Akari Therapeutics PLC
Market & Valuation
Market Cap	$15M	$17M
Enterprise Value	$11M	$10M
Price	$0.61	$8.77
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	19.88x	0.83x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.53x	-0.94x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	50.1%	137.9%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-20M	$-31M
FCF (TTM)	$-20M	$-11M
EPS (TTM)	-$0.86	-$0.40
ROE (TTM)	-34618.0%	-14745.0%
ROA (TTM)	-17840.0%	-7470.0%
ROIC (TTM)	-32397.0%	-14027.0%
Financial Health
Cash	$4M	$8M
Debt	$405K	$693K
Net Cash/Debt	$4M	$7M
Current Ratio (TTM)	1.25x	0.60x
Quick Ratio (TTM)	1.16x	0.56x
Debt/Equity (TTM)	0.41x	0.04x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.66	1.48
52W Performance	-91.3%	-78.5%
YTD Performance	-89.9%	-24.4%
% from 52W High	-92.8%	-79.5%
% from 52W Low	1.0%	190.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-135.8%	-63.0%
Earnings Yield (TTM)	-140.1%	-181.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACTU research	View AKTX research

Valuation

P/S Ratio

ACTU

0.00x

AKTX

0.00x

EV/FCF

AKTX

-0.94x

ACTU

-0.53x

Growth & revenue

Forward Revenue Growth

AKTX

137.9%

ACTU

50.1%

Profitability & performance

Gross Margin

ACTU

0.0%

AKTX

0.0%

ROE

AKTX

-14745.0%

ACTU

-34618.0%

FCF Yield %

AKTX

-63.0%

ACTU

-135.8%

52-Week Performance

AKTX

-78.5%

ACTU

-91.3%

Detailed metrics comparison

ACTU

Actuate Therapeutics Inc

AKTX

Akari Therapeutics PLC

Market Cap

ACTU$15M

AKTX$17M

Enterprise Value

ACTU$11M

AKTX$10M

Price

ACTU$0.61

AKTX$8.77

P/E Ratio

ACTUN/A

AKTXN/A

P/S Ratio

ACTU0.00x

AKTX0.00x

EV/Sales

ACTU0.00x

AKTX0.00x

EV/EBITDA

ACTU0.00x

AKTX0.00x

P/B Ratio

ACTU19.88x

AKTX0.83x

P/FCF Ratio

ACTUN/A

AKTXN/A

EV/FCF

ACTU-0.53x

AKTX-0.94x

PEG Ratio

ACTUN/A

AKTXN/A

Forward P/E (NTM)

ACTUN/A

AKTXN/A

Forward P/S (NTM)

ACTUN/A

AKTXN/A

Revenue (TTM)

ACTU$0

AKTX$0

Revenue Growth (YoY)

ACTUN/A

AKTXN/A

Forward Rev Growth

ACTU50.1%

AKTX137.9%

Gross Margin (TTM)

ACTU0.0%

AKTX0.0%

Operating Margin (TTM)

ACTU0.0%

AKTX0.0%

EBITDA Margin (TTM)

ACTU0.0%

AKTX0.0%

Net Margin (TTM)

ACTU0.0%

AKTX0.0%

FCF Margin (TTM)

ACTUN/A

AKTXN/A

Net Income (TTM)

ACTU$-20M

AKTX$-31M

FCF (TTM)

ACTU$-20M

AKTX$-11M

EPS (TTM)

ACTU-$0.86

AKTX-$0.40

ROE (TTM)

ACTU-34618.0%

AKTX-14745.0%

ROA (TTM)

ACTU-17840.0%

AKTX-7470.0%

ROIC (TTM)

ACTU-32397.0%

AKTX-14027.0%

Cash

ACTU$4M

AKTX$8M

Debt

ACTU$405K

AKTX$693K

Net Cash/Debt

ACTU$4M

AKTX$7M

Current Ratio (TTM)

ACTU1.25x

AKTX0.60x

Quick Ratio (TTM)

ACTU1.16x

AKTX0.56x

Debt/Equity (TTM)

ACTU0.41x

AKTX0.04x

Debt/Assets (TTM)

ACTU0.0%

AKTX0.0%

Interest Coverage (TTM)

ACTUN/A

AKTXN/A

Net Debt/EBITDA (TTM)

ACTU0.00x

AKTX0.00x

Beta

ACTU1.66

AKTX1.48

52W Performance

ACTU-91.3%

AKTX-78.5%

YTD Performance

ACTU-89.9%

AKTX-24.4%

% from 52W High

ACTU-92.8%

AKTX-79.5%

% from 52W Low

ACTU1.0%

AKTX190.4%

Asset Turnover (TTM)

ACTU0.00x

AKTX0.00x

FCF Yield (TTM)

ACTU-135.8%

AKTX-63.0%

Earnings Yield (TTM)

ACTU-140.1%

AKTX-181.3%

Dividend Yield (TTM)

ACTUN/A

AKTXN/A

Rule of 40

ACTU0.0

AKTX0.0

EV/GP/RG

ACTUN/A

AKTXN/A

Ticker research

View ACTU research View AKTX research

Metric	ACTU Actuate Therapeutics Inc	AKTX Akari Therapeutics PLC
Market & Valuation
Market Cap	$15M	$17M
Enterprise Value	$11M	$10M
Price	$0.61	$8.77
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	19.88x	0.83x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.53x	-0.94x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	50.1%	137.9%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-20M	$-31M
FCF (TTM)	$-20M	$-11M
EPS (TTM)	-$0.86	-$0.40
ROE (TTM)	-34618.0%	-14745.0%
ROA (TTM)	-17840.0%	-7470.0%
ROIC (TTM)	-32397.0%	-14027.0%
Financial Health
Cash	$4M	$8M
Debt	$405K	$693K
Net Cash/Debt	$4M	$7M
Current Ratio (TTM)	1.25x	0.60x
Quick Ratio (TTM)	1.16x	0.56x
Debt/Equity (TTM)	0.41x	0.04x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.66	1.48
52W Performance	-91.3%	-78.5%
YTD Performance	-89.9%	-24.4%
% from 52W High	-92.8%	-79.5%
% from 52W Low	1.0%	190.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-135.8%	-63.0%
Earnings Yield (TTM)	-140.1%	-181.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACTU research	View AKTX research